Company · CIK 2058707

# Attovia Therapeutics, Inc.

| CIK | [2058707](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002058707) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | ATTO (Nasdaq) |
| First annual or quarterly report | 2026-09-02 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-297452 | IPO Final prospectus | 2026-07-14 | 2026-08-05 | 5 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-08-05 | [424B4](https://www.sec.gov/Archives/edgar/data/2058707/000119312526334997/0001193125-26-334997-index.htm) Final prospectus | 333-297452 | 0001193125-26-334997 |
| 2026-08-04 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2058707/999999999526002535/9999999995-26-002535-index.htm) Declared effective | 333-297452 | 9999999995-26-002535 |
| 2026-08-04 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2058707/000119312526331510/0001193125-26-331510-index.htm) Amendment | 333-297452 | 0001193125-26-331510 |
| 2026-07-29 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2058707/000119312526323618/0001193125-26-323618-index.htm) Amendment | 333-297452 | 0001193125-26-323618 |
| 2026-07-14 | [S-1](https://www.sec.gov/Archives/edgar/data/2058707/000119312526303256/0001193125-26-303256-index.htm) Registration filed | 333-297452 | 0001193125-26-303256 |
| 2025-12-19 | [DRS](https://www.sec.gov/Archives/edgar/data/2058707/000119312525326945/0001193125-25-326945-index.htm) Draft made public | 377-08845 | 0001193125-25-326945 |

[All filings of this company](https://equitycapital.markets/filings?cik=2058707) · [CSV](https://equitycapital.markets/filings.csv?cik=2058707)

---
Source page: https://equitycapital.markets/company/2058707 · Data: U.S. SEC EDGAR · CC BY 4.0